Literature DB >> 23708831

Role of interleukin-10 and interleukin-10 receptor in systemic lupus erythematosus.

Hui Peng1, Wei Wang, Mo Zhou, Rui Li, Hai-Feng Pan, Dong-Qing Ye.   

Abstract

Systemic lupus erythematosus (SLE) is a prototypic autoimmune disease characterized by excessive production of a variety of autoantibodies, accumulation of immune complexes, and multiple organ systems involvement. Interleukin-10 (IL-10) has an important role in the growth, survival, differentiation, and function of B cells. Abnormally increased IL-10 synthesis seems contributing to the spontaneous hyperactivity of the B cell compartment, so that it can directly result in autoantibody production by committed plasma cells, circulating immune complexes formation, and eventually in tissue and organ damage, suggesting it might associate with the development of SLE. A better understanding of the regulation of IL-10 and its receptors (IL-10R) can likely provide more valuable clues to the pathogenic mechanisms underlying specific forms of SLE, so as to pave the way toward more effective therapeutics.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23708831     DOI: 10.1007/s10067-013-2294-3

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  129 in total

1.  Association tests with systemic lupus erythematosus (SLE) of IL10 markers indicate a direct involvement of a CA repeat in the 5' regulatory region.

Authors:  S D' Alfonso; M Giordano; M Mellai; M Lanceni; N Barizzone; M Marchini; R Scorza; M G Danieli; M Cappelli; P Rovere; M G Sabbadini; P Momigliano-Richiardi
Journal:  Genes Immun       Date:  2002-12       Impact factor: 2.676

2.  Interleukin-10 receptor expression in systemic lupus erythematosus and rheumatoid arthritis.

Authors:  A P Cairns; A D Crockard; A L Bell
Journal:  Clin Exp Rheumatol       Date:  2003 Jan-Feb       Impact factor: 4.473

3.  Association between polymorphisms at the human IL-10 locus and systemic lupus erythematosus.

Authors:  J Eskdale; P Wordsworth; S Bowman; M Field; G Gallagher
Journal:  Tissue Antigens       Date:  1997-06

4.  Genetic variation in the interleukin 10 gene promoter and systemic lupus erythematosus.

Authors:  M Lazarus; A H Hajeer; D Turner; P Sinnott; J Worthington; W E Ollier; I V Hutchinson
Journal:  J Rheumatol       Date:  1997-12       Impact factor: 4.666

Review 5.  The role of Tumor Necrosis Factor-alpha (TNF-α) in the pathogenesis of systemic lupus erythematosus.

Authors:  Mariana Postal; Simone Appenzeller
Journal:  Cytokine       Date:  2011-09-09       Impact factor: 3.861

6.  Interferon-gamma is required for lupus-like disease and lymphoaccumulation in MRL-lpr mice.

Authors:  D Balomenos; R Rumold; A N Theofilopoulos
Journal:  J Clin Invest       Date:  1998-01-15       Impact factor: 14.808

7.  Increased CCR4 expression on circulating CD4(+) T cells in ankylosing spondylitis, rheumatoid arthritis and systemic lupus erythematosus.

Authors:  P T Yang; H Kasai; L J Zhao; W G Xiao; F Tanabe; M Ito
Journal:  Clin Exp Immunol       Date:  2004-11       Impact factor: 4.330

8.  Comparison of interleukin-22 and interleukin-10 soluble receptor complexes.

Authors:  Naomi J Logsdon; Brandi C Jones; Kristopher Josephson; Jennifer Cook; Mark R Walter
Journal:  J Interferon Cytokine Res       Date:  2002-11       Impact factor: 2.607

9.  Genetic analysis of interleukin-10 promoter region in patients with systemic lupus erythematosus in Taiwan.

Authors:  T T Ou; W C Tsai; C J Chen; J G Chang; J H Yen; W S Wang; C H Lin; J J Tsai; H W Liu
Journal:  Kaohsiung J Med Sci       Date:  1998-10       Impact factor: 2.744

10.  Accumulation of splenic B1a cells with potent antigen-presenting capability in NZM2410 lupus-prone mice.

Authors:  C Mohan; L Morel; P Yang; E K Wakeland
Journal:  Arthritis Rheum       Date:  1998-09
View more
  29 in total

Review 1.  The Post-GWAS Era: How to Validate the Contribution of Gene Variants in Lupus.

Authors:  Adam J Fike; Irina Elcheva; Ziaur S M Rahman
Journal:  Curr Rheumatol Rep       Date:  2019-01-23       Impact factor: 4.592

2.  Effects of adjuvants for human use in systemic lupus erythematosus (SLE)-prone (New Zealand black/New Zealand white) F1 mice.

Authors:  E Favoino; E I Favia; L Digiglio; V Racanelli; Y Shoenfeld; F Perosa
Journal:  Clin Exp Immunol       Date:  2014-01       Impact factor: 4.330

3.  Genetic variant of IL-10RA and susceptibility to rheumatoid arthritis in a Chinese population.

Authors:  Xiao-Ke Yang; Peng Li; Song Li; Chao Zhang; Bao-Zhu Li; Rui-Xue Leng; Hai-Feng Pan; Dong-Qing Ye
Journal:  Clin Rheumatol       Date:  2016-10-29       Impact factor: 2.980

Review 4.  DNA methylation in systemic lupus erythematosus.

Authors:  Christian M Hedrich; Katrin Mäbert; Thomas Rauen; George C Tsokos
Journal:  Epigenomics       Date:  2016-11-25       Impact factor: 4.778

5.  Stat3 promotes IL-10 expression in lupus T cells through trans-activation and chromatin remodeling.

Authors:  Christian M Hedrich; Thomas Rauen; Sokratis A Apostolidis; Alexandros P Grammatikos; Noe Rodriguez Rodriguez; Christina Ioannidis; Vasileios C Kyttaris; Jose C Crispin; George C Tsokos
Journal:  Proc Natl Acad Sci U S A       Date:  2014-09-03       Impact factor: 11.205

Review 6.  T follicular helper cells, T follicular regulatory cells and autoimmunity.

Authors:  Yangyang Zhu; Le Zou; Yun-Cai Liu
Journal:  Int Immunol       Date:  2015-12-29       Impact factor: 4.823

Review 7.  New treatments for inflammatory rheumatic disease.

Authors:  Carlo Selmi; Elena Generali; Marco Massarotti; Gerolamo Bianchi; Carlo A Sciré
Journal:  Immunol Res       Date:  2014-12       Impact factor: 2.829

8.  Refractory ascites in systemic lupus erythematosus: further biological support of intraperitoneal steroid treatment as a suitable therapeutical option.

Authors:  Yemil Atisha-Fregoso; Diego F Hernández-Ramírez; Elizabeth Olivares-Martínez; Carlos A Núñez-Alvarez; Luis Llorente; Gabriela Hernández-Molina
Journal:  Clin Rheumatol       Date:  2016-11-09       Impact factor: 2.980

9.  C/EBP β mRNA expression is upregulated and positively correlated with the expression of TNIP1/TNFAIP3 in peripheral blood mononuclear cells from patients with systemic lupus erythematosus.

Authors:  Tian Qian; Yan Chen; Xiaowei Shi; Jian Li; Fei Hao; Dongmei Zhang
Journal:  Exp Ther Med       Date:  2016-08-23       Impact factor: 2.447

10.  IL-10-Induced miR-155 Targets SOCS1 To Enhance IgE-Mediated Mast Cell Function.

Authors:  Amina Abdul Qayum; Anuya Paranjape; Daniel Abebayehu; Elizabeth Motunrayo Kolawole; Tamara T Haque; Jamie Josephine Avila McLeod; Andrew J Spence; Heather L Caslin; Marcela T Taruselli; Alena P Chumanevich; Bianca Baker; Carole A Oskeritzian; John J Ryan
Journal:  J Immunol       Date:  2016-04-29       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.